MicroRNA-30b Is Both Necessary and Sufficient for Interleukin-21 Receptor-Mediated Angiogenesis in Experimental Peripheral Arterial Disease is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: RO1 HL121635
National Institutes of Health
Grant: R01HL141325
National Institute of Health
Grant: R01HL148590
National Institute of Health
Grant: R01HL101200
National Institute of Health
Grant: R01GM129074
National Institute of Health
Grant: 7R01HL146673-02
A two amino acid switch in the anti-angiogenic VEGF165b isoform creates a novel agent for therapeutic angiogenesis in peripheral artery disease
Natural Science Foundation of China
Grant: 81700426
Natural Science Foundation of China
Grant: 81970046
National Institutes of Health
Grant: 5R01HL101200-04
Systems Biology of Angiogenesis in Peripheral Arterial Disease
National Institutes of Health
Grant: 1R01HL148590-01
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R Pathway
National Institutes of Health
Grant: 1R01GM129074-01
New Roles for VEGFR1 in Angiogenesis
National Institutes of Health
Grant: 5R01HL141325-03
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease
National Institutes of Health
Grant: 1R01HL121635-01A1
MicroRNA 93 in Peripheral Arterial Disease
NHLBI NIH HHS
Grant: R01 HL150003
NHLBI NIH HHS
Grant: R01 HL146673
FWCI
0.89
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals